JP2020513780A5 - - Google Patents

Download PDF

Info

Publication number
JP2020513780A5
JP2020513780A5 JP2019538207A JP2019538207A JP2020513780A5 JP 2020513780 A5 JP2020513780 A5 JP 2020513780A5 JP 2019538207 A JP2019538207 A JP 2019538207A JP 2019538207 A JP2019538207 A JP 2019538207A JP 2020513780 A5 JP2020513780 A5 JP 2020513780A5
Authority
JP
Japan
Prior art keywords
strain
use according
probiotic
probiotic lactobacillus
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019538207A
Other languages
English (en)
Japanese (ja)
Other versions
JP7089523B2 (ja
JP2020513780A (ja
Filing date
Publication date
Priority claimed from GBGB1700542.2A external-priority patent/GB201700542D0/en
Priority claimed from GBGB1709731.2A external-priority patent/GB201709731D0/en
Application filed filed Critical
Priority claimed from PCT/EP2018/050789 external-priority patent/WO2018130667A1/en
Publication of JP2020513780A publication Critical patent/JP2020513780A/ja
Publication of JP2020513780A5 publication Critical patent/JP2020513780A5/ja
Application granted granted Critical
Publication of JP7089523B2 publication Critical patent/JP7089523B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019538207A 2017-01-12 2018-01-12 プロバイオティクス組成物およびその使用 Active JP7089523B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB1700542.2A GB201700542D0 (en) 2017-01-12 2017-01-12 Probiotic compositions and uses thereof
GB1700542.2 2017-01-12
GBGB1709731.2A GB201709731D0 (en) 2017-06-19 2017-06-19 Probiotic compositions and uses thereof
GB1709731.2 2017-06-19
PCT/EP2018/050789 WO2018130667A1 (en) 2017-01-12 2018-01-12 Probiotic compositions and uses thereof

Publications (3)

Publication Number Publication Date
JP2020513780A JP2020513780A (ja) 2020-05-21
JP2020513780A5 true JP2020513780A5 (enExample) 2021-02-25
JP7089523B2 JP7089523B2 (ja) 2022-06-22

Family

ID=61386800

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019538207A Active JP7089523B2 (ja) 2017-01-12 2018-01-12 プロバイオティクス組成物およびその使用

Country Status (13)

Country Link
US (1) US11166993B2 (enExample)
EP (1) EP3568144B1 (enExample)
JP (1) JP7089523B2 (enExample)
KR (1) KR102500496B1 (enExample)
CN (1) CN110177561B (enExample)
AU (1) AU2018207946B2 (enExample)
CA (1) CA3049624A1 (enExample)
CL (1) CL2019001938A1 (enExample)
MX (1) MX2019008292A (enExample)
MY (1) MY195253A (enExample)
PH (1) PH12019501629A1 (enExample)
RU (1) RU2763311C2 (enExample)
WO (1) WO2018130667A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112584848A (zh) * 2018-06-18 2021-03-30 普罗比公司 益生菌组合物及其用途
IT201900014550A1 (it) * 2019-08-09 2021-02-09 Abiogen Pharma Spa Uso di colecalciferolo come agente attivo nel trattamento della celiachia
CN116869141A (zh) * 2022-05-05 2023-10-13 内蒙古一康健康发展有限责任公司 一种具有保健功能的益生菌复合物及其制备方法
KR102845919B1 (ko) * 2023-02-28 2025-08-14 주식회사 피엘비앤비 장내 유해세균의 성장 억제 성능이 우수한 한국인 모유 유래 락티카제이바실러스 파라카제이 pl1536 및 이를 유효성분으로 포함하는 기능성식품 조성물
CN119279210A (zh) * 2024-12-16 2025-01-10 山东健源生物科技有限公司 一种复合益生菌发酵含药食同源物质的多谷物后生元制剂及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004076615A2 (en) * 2003-02-27 2004-09-10 Bioneer A/S Immunomodulating probiotic compounds
WO2006097949A1 (en) * 2005-03-16 2006-09-21 Actial Farmacêutica, Lda. Mixture of at least 6 species of lactic acid bacteria and/or bifidobacteria in the manufacture of sourdough
ZA200802934B (en) * 2005-10-06 2009-09-30 Probi Ab Use of lactobacillus for treatment of virus infections
KR101300086B1 (ko) * 2005-10-06 2013-08-30 프로비 아베 자가면역질환의 치료를 위한 락토바실러스의 용도
WO2007108763A1 (en) 2006-03-17 2007-09-27 Probac Ab Use of lactobacillus strains for promoting immunotolerance in autoimmune disease
US8137952B2 (en) 2006-03-17 2012-03-20 Probac Ab Thermostable lactobacillus strains
EP3269379A1 (en) 2008-11-30 2018-01-17 Immusant, Inc. Compositions and methods for treatment of celiac disease
EP2581461B1 (en) * 2011-10-14 2014-09-24 GenMont Biotech Incorporation Composition and use of lactobacillus paracasei strain GMNL-133 in treating atopic dermatitis or other allergic diseases
MX363899B (es) 2012-06-18 2019-04-05 Heinz Co Brands H J Llc Trastornos relacionados con gluten.
KR102129934B1 (ko) * 2013-04-03 2020-07-03 프로비 아베 골다공증의 치료 또는 예방에 사용되는 프로바이오틱 스트레인
WO2016083450A2 (en) * 2014-11-25 2016-06-02 Stichting Top Institute Food And Nutrition New probiotic and new biomarker

Similar Documents

Publication Publication Date Title
JP2004524836A5 (enExample)
Sood et al. The probiotic preparation, VSL# 3 induces remission in patients with mild-to-moderately active ulcerative colitis
Villena et al. Intestinal innate antiviral immunity and immunobiotics: beneficial effects against rotavirus infection
Khalighi et al. Probiotics: A Comprehensive Review of Their
JP2021527104A5 (enExample)
Chatterjee et al. Probiotics in periodontal health and disease
ES2761333T3 (es) Composiciones farmacéuticas que contienen Pediococcus y métodos para reducir los síntomas de síndromes gastroenterológicos
RU2009139657A (ru) Снижение риска диареи
US20200121740A1 (en) Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes
CA2434337A1 (en) Combination of probiotics
JP2017537156A5 (enExample)
CA2783414A1 (en) Probiotic composition
TW201636034A (zh) 細菌組成物
JP2016537410A5 (enExample)
BR112016031000B1 (pt) Forma de dosagem em camadas e método para fazer a mesma
JP2015525566A5 (enExample)
JP2019535828A5 (enExample)
JP6945888B1 (ja) 免疫機能向上用組成物
CN104366486A (zh) 五联益生菌咀嚼片的配方及制备方法
RU2019121145A (ru) Пробиотические композиции и их применение
GB2623930A (en) Probiotic compositions for treating and preventing colorectal cancer
JP2018531598A5 (enExample)
JP2018535940A5 (enExample)
Böhm et al. Microbiome-modulating strategies in anticancer therapy: a review of current evidence and recommendations for further treatment improvement
Tafla et al. Exploring the Potential of Biotics in Cancer Prevention and Treatment—Mechanisms, Experimental, and Clinical Insights.